Atlas Trials

Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT01606241 · COMPLETED

Trial details

NCT number
NCT01606241
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaStage IIA Breast CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIB Breast CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIC Fallopian Tube CancerStage IIC Ovarian Cancer
Start date
2012-07-24
Primary completion
2014-09-25
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.